Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiesner

Showing results (391-400 of 432) with videos related to

Pageof 44
Sort By:
Gastroenterology|May 1, 1994
Ursodeoxycholic acid in the treatment of primary biliary cirrhosisK D Lindor, E R Dickson, W P Baldus, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis CB J Veldt, J J Poterucha, K D S Watt, et al.
Transplantation|October 15, 1996
Risk factors of invasive Candida and non-Candida fungal infections after liver transplantationR Patel, D Portela, A D Badley, et al.
Hepatology (Baltimore, Md.)|October 1, 1989
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysisR H Wiesner, P M Grambsch, E R Dickson, et al.
Hepatology (Baltimore, Md.)|July 10, 1998
Optimal timing of liver transplantation for primary biliary cirrhosisW R Kim, R H Wiesner, T M Therneau, et al.
Transplantation|March 8, 2000
The economic impact of cytomegalovirus infection after liver transplantationW R Kim, A D Badley, R H Wiesner, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot studyK D Lindor, E R Dickson, R A Jorgensen, et al.
Antiviral Therapy|February 17, 2007
Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis CVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Transplantation|December 10, 1999
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development MeetingC V Paya, J J Fung, M A Nalesnik, et al.
Mayo Clinic Proceedings|February 1, 1994
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantationM K Porayko, S C Textor, R A Krom, et al.
Pageof 44

Showing results (391-400 of 432) with videos related to

Sort By:
Pageof 44
Gastroenterology|May 1, 1994
Ursodeoxycholic acid in the treatment of primary biliary cirrhosisK D Lindor, E R Dickson, W P Baldus, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis CB J Veldt, J J Poterucha, K D S Watt, et al.
Transplantation|October 15, 1996
Risk factors of invasive Candida and non-Candida fungal infections after liver transplantationR Patel, D Portela, A D Badley, et al.
Hepatology (Baltimore, Md.)|October 1, 1989
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysisR H Wiesner, P M Grambsch, E R Dickson, et al.
Hepatology (Baltimore, Md.)|July 10, 1998
Optimal timing of liver transplantation for primary biliary cirrhosisW R Kim, R H Wiesner, T M Therneau, et al.
Transplantation|March 8, 2000
The economic impact of cytomegalovirus infection after liver transplantationW R Kim, A D Badley, R H Wiesner, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot studyK D Lindor, E R Dickson, R A Jorgensen, et al.
Antiviral Therapy|February 17, 2007
Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis CVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Transplantation|December 10, 1999
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development MeetingC V Paya, J J Fung, M A Nalesnik, et al.
Mayo Clinic Proceedings|February 1, 1994
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantationM K Porayko, S C Textor, R A Krom, et al.
Pageof 44